Back to search
Vitiligo, Generalized
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Vitiligo, Generalized trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Vitiligo, Generalized trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Vitiligo affects approximately 1 to 2% of the global population and significantly impacts people's quality of life. Achieving the best treatment outcomes for vi…
This study aims to compare the efficacy and safety of PUVA versus Tofacitinib in the treatment of generalized vitiligo. Given the high prevalence of vitiligo in…